Table 1.
Clinical characteristics
| Patients with lung cancer n = 14 | Patients with ILD n = 10 | Patients with asthma n = 10 | |
|---|---|---|---|
| Sex (male:female) | 7:7 | 6:4 | 3:7 |
| Age (years; mean ± STD) | 66.6 ± 8.6 | 60.0 ± 14.5 | 51.5 ± 17.6 |
| Lung function* | |||
| FEV1/FVC (%; mean ± SD) | 63 ± 14 | 80 ± 5 | 71 ± 10 |
| FEV1 (%; mean ± SD) | 76.6 ± 21.5 | 84.6 ± 22.1 | 86.0 ± 25.3 |
| FVC (%; mean ± SD) | 93.5 ± 15.9 | 87.4 ± 21.0 | 95.9 ± 21.2 |
| Histology (n; %) | |||
| Adenocarcinoma | 6 | – | – |
| Squamous cell carcinoma | 6 | – | – |
| Pleomorphic carcinoma | 1 | – | – |
| NOS | 1 | – | – |
| Stage of disease (n; %) | |||
| IA3 | 2 | – | – |
| IB | 1 | – | – |
| IIB | 2 | – | – |
| IIIA | 3 | – | – |
| IIIC | 1 | – | – |
| IVA | 2 | – | – |
| IVB | 3 | – | – |
*Not available for 2 patients with lung cancer and 2 patients with asthma